Roquefort Therapeutics Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.18%
Shares Change (QoQ)	+12.76%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.08.

Current Ratio	2.80
Quick Ratio	0.34
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.59
Interest Coverage	-17.40

Financial Efficiency

Return on equity (ROE) is -18.23% and return on invested capital (ROIC) is -10.91%.

Return on Equity (ROE)	-18.23%
Return on Assets (ROA)	-9.93%
Return on Invested Capital (ROIC)	-10.91%
Return on Capital Employed (ROCE)	-18.51%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-126,064
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-161,371
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.86% in the last 52 weeks. The beta is -0.56, so LON:ROQ's price volatility has been lower than the market average.

Beta (5Y)	-0.56
52-Week Price Change	-94.86%
50-Day Moving Average	9.08
200-Day Moving Average	14.47
Relative Strength Index (RSI)	46.22
Average Volume (20 Days)	142,108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-932,135
Pretax Income	-1.04M
Net Income	-882,451
EBITDA	-926,731
EBIT	-932,135
Earnings Per Share (EPS)	-0.06

Full Income Statement

Balance Sheet

The company has 182,923 in cash and 383,650 in debt, with a net cash position of -200,727.

Cash & Cash Equivalents	182,923
Total Debt	383,650
Net Cash	-200,727
Net Cash Per Share	n/a
Equity (Book Value)	4.75M
Book Value Per Share	0.30
Working Capital	1.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -588,753 and capital expenditures -56,865, giving a free cash flow of -645,618.

Operating Cash Flow	-588,753
Capital Expenditures	-56,865
Depreciation & Amortization	5,404
Net Borrowing	n/a
Free Cash Flow	-645,618
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:ROQ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.18%
Shareholder Yield	-4.18%
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2